Lancet
-
As life expectancy improves in patients with lung cancer and bone metastases, effective surgical treatment to relieve pain and improve quality of life and neurological function is increasingly needed. Indications for surgery in patients with bone metastases are controversial. We aimed to assess a protocol for the surgery of patients with lung cancer and bone metastases. ⋯ National Natural Science Foundation of China Grant (81201628).
-
Genome-wide association studies (GWAS) have provided insight into cancer genetics. However, molecular mechanisms whereby many susceptibility single nucleotide polymorphisms (SNPs) identified by GWAS promote cancer heritability and risk are unknown. New research strategies to evaluate functionality are needed to systematically study causal genetic variants. ⋯ National Natural Science Foundation of China (81201586 and 31271382), National High-Tech Research and Development Program of China (2015AA020950), State Key Laboratory of Molecular Oncology (SKL-KF-2015-05).
-
To help drive the consolidation and integrated management of basic medical insurance in China, we analysed participants' satisfaction, and factors associated with satisfaction, for the Urban Employees' Basic Medical Insurance (UEBMI), Urban Residents' Basic Medical Insurance (URBMI), and New Rural Cooperative Medical Scheme (NRCMS). ⋯ Funded by the National Nature Science Foundation of China (NSFC 71503170), Shanghai Municipal Commission of Health and Family Planning (201440036, 2016HP009).
-
According to Chinese medicinal literature, Euphorbia Pekinensis and Glycyrrhiza should not be used together because of their antagonistic actions. However, increasing experimental and clinical evidence show that they exhibit synergistic or antagonistic actions when used together in different combinations. The aim of this study was to clarify the herbaceous compatibility of Euphorbia Pekinensis and Glycyrrhiza acting on hepatocellular carcinoma (HCC) ascites, which has not been fully elucidated. ⋯ The National Basic Research Program of China (973 Program) (2011CB505300, 2011CB505305), the National Natural Science Foundation of China (81303153), Beijing Nova program (Z1511000003150126), and the Prospective Study Platform Project of Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences (QZPT002).
-
In 2015, WHO recommended universal antiretroviral treatment for HIV irrespective of CD4 cell count. The impact of this recommendation on heterosexual HIV transmission, especially in low prevalence countries, has not been well-characterised. In Hong Kong, 38% of reported HIV cases are heterosexually acquired. We aimed to model the impacts of enhanced HIV testing and immediate treatment to provide a reference to other provinces in China. ⋯ Council for the AIDS Trust Fund.